HDAC9 and amyotrophic lateral sclerosis: It is worth pointing out that HDAC inhibitors have been shown to acetylate not just the K315/K316 but also the K510 residue (Arenas et al., 2020), though the use of HDAC inhibitors has thus far shown solely beneficial effects in FUS-ALS.